1. Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline no. 9. In: AHCPR publication No. 94?0592. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services. Public Health Service, 1994.
2. World Health Organization: Cancer Pain Relief: A Guide to Opioid Availability , 2nd ed. Geneva: WHO; 1996.
3. American Academy of Pain Medicine and American Pain Society. The Use of Opioids for the Treatment of Chronic Pain: A Consensus Statement ; 1996. www.ampainsoc.org
4. American Pain Society. Chronic Pain in America: Roadblocks to Relief. www.ampainsoc.org
5. Bigos S, Bowyer O, Braen G, et al. Acute low back problems in adults. Clinical practice guideline No. 14. In: AHCPR Publication No. 95-0642. Rockville, MD: Agency for Health Care Policy and Research, U.S. Department of Health and Human Services. Public Health Service, 1994.
6. Cleeland CS. The impact of pain on the patient with cancer. Cancer 1984;54:2635-2641.
7. Portenoy RK. Issues in the economic analysis of therapies for cancer pain. Oncology . 1995;9(suppl):71-78.
8. The Nuprin pain report / conducted for Nuprin [by] Louis Harris and Associates, Inc. ; project directors, Humphrey Taylor, Nancy Morency Curran. -- New York, NY: L. Harris and Associates, [1985] 233 p28 cm. "September 1985."
9. The impacts of pain: Assessing and managing its costs in the workplace. Business and Health (Special Issue). 1997.
10. Louis Harris and Associates, Inc. The pain and absenteeism report: A study of full-time employees and employee benefit managers. New York: Author. 1996.
11. Nurmikko TJ, Nash TB, Wiles JR. Control of chronic pain. BMJ . 1998;317:1438-1441.
12. Milligan K, Lanteri-Minet M, Borchert K, et al. Evaluation of long-term efficacy and safety of transdermal fentanyl in the treatment of chronic noncancer pain. J Pain . 2001;2:197-204.
13. Woodroffe MA, Hays H. Fentanyl transdermal system: pain management at home. Can Fam Physician . 1997;43:268-272.
14. Baumrucker SJ. Duragesic (transdermal fentanyl) in hospice care. Am J Hosp Palliat Care . 1996;13:13-15.
15. Passik SD, Portenoy RK. Substance abuse issues in palliative care. In Berger A, Portenoy RK, Weissman D, eds. Principles and Practice of Supportive Oncology , 2nd ed. Philadelphia, PA: Lippincott-Raven Publishers; 1998:513-529.
16. Portenoy RK, Payne R: Acute and chronic pain. In: Lowinson JH, Ruiz P, Millman RB, eds. Comprehensive Textbook of Substance Abuse , 3rd ed. Baltimore, MD: Williams & Wilkins; 1997:563-589
17. Joranson DE, Gilson AM. Regulatory barriers to pain management. Semin Oncol Nurs. 1998;14:158-163.
18. Von Roenn JH, Cleeland CS, Gonin R, et al. Physician attitudes and practice in cancer pain management: A survey from the Eastern Cooperative Oncology Group. Ann Intern Med . 1993;119:121-126.
19. Benjamin LJ, Dampier CC, Jacox AK, et al. Guideline for the management of acute and chronic pain in sickle-cell disease. In: APS clinical practice guideline series No. 1. Glenview, IL: American Pain Society; 1999.

Go Back to Page 2     Go Back to Page 1     Go Back to Tools page